Acasti Pharma Inc. Announces the Resignation of a Director :

/PRNewswire/ -- Acasti Pharma Inc. ("Acasti" or the "Company") (NASDAQ: ACST) a late-stage, specialty pharma company advancing three clinical stage drug...

Related Keywords

Canada , United States , Canadian , Jean Marie John Canan , Robert Blum , Jan Dalvise , Prnewswire Acasti Pharma Inc , Nasdaq , Board Of Directors The Company , Acasti Pharma Inc , Securities Exchange , Lytham Partners , Orphan Drug Designation , Subarachnoid Hemorrhage , Postherpetic Neuralgia , Securities Litigation Reform Act , Securities Act , Securities Exchange Act ,